Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 30 October 2019, 08:18 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Proton Therapy Opens at Sibley Memorial Hospital, a Member of Johns Hopkins Medicine, US Top-Ranked Healthcare Institution

TOKYO, Oct 30, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has announced that Hitachi has provided its advanced proton therapy system to Sibley Memorial Hospital (Washington DC, US), a member of Johns Hopkins Medicine (Maryland, US), and it has started treatment on October 25, 2019. On October 28, an opening ceremony at Sibley Memorial Hospital was held.




The proton therapy system installed at Sibley includes spot scanning technology that sends a therapeutic proton beam precisely conforming to the shape of the target tumor. It has three rotating gantry treatment rooms and one fixed beam research room. This is the first Hitachi system in the US with Real-time Gated Proton Therapy capability, which allows real-time beam irradiation to the tumor while compensating for movement associated with respiration.

Johns Hopkins Medicine, based in Baltimore, Maryland, US, is a world-class hospital focusing on medical research and clinical care. Johns Hopkins Hospital has maintained its position as one of the top hospitals in U.S. News & World Report rankings for decades. Sibley Memorial Hospital, an affiliate of Johns Hopkins Medicine, provides cancer care from the world-renowned Johns Hopkins

Sidney Kimmel Comprehensive Cancer

Center which also has one of the most successful cancer research programs in the world.
Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will continue to accelerate the globalization of its particle therapy system business and contribute to cancer treatment around the world.

* U.S. News & World Report releases its Best Hospitals rankings in the country every year.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.

For more information on Hitachi's Particle Therapy System
http://www.hitachi.com/businesses/healthcare/products-support/pbt/


About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business that combines information technology (IT), operational technology (OT) and products. The company's consolidated revenues for fiscal 2019 (ended March 31, 2020) totaled 8,767.2 billion yen ($80.4 billion), and the number of employees was approximately 301,000 worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase social, environmental and economic values of its customers. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111


Oct 30, 2019 08:18 HKT/SGT
Source: Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501)

Topic: Press release summary
Sectors: BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd.
July 22, 2020 16:36 HKT/SGT
Hitachi to Support for Researches on Infectious Diseases through The Hitachi Global Foundation
July 15, 2020 19:05 HKT/SGT
Hitachi ABB Power Grids Launches Game-changing EV Charging System for Large-scale e-Mobility
July 15, 2020 16:14 HKT/SGT
Hitachi Kicks Off "Hitachi Origin Story" Website
July 10, 2020 08:07 HKT/SGT
Hitachi ABB Power Grids India Wins INR 120 Crore Order for Indian Railways Electrification
July 6, 2020 16:39 HKT/SGT
HOYA and Hitachi Announce Long Term Technical Collaboration and Supply Agreement Related to Endoscopic Ultrasound Systems
June 26, 2020 13:00 HKT/SGT
Hitachi and Microsoft Form a Strategic Alliance to Advance Next-generation Digital Solutions for Manufacturing and Logistics across Southeast Asia, North America and Japan
June 23, 2020 15:00 HKT/SGT
SDK Subsidiary, Hitachi Chemical Changes Name
June 11, 2020 12:50 HKT/SGT
Hitachi: Establishment of and Participation in the ESG Disclosure Study Group Comprised of 19 Companies in the Private Sector
June 8, 2020 08:00 HKT/SGT
Hitachi Provides a Free Cloud Service for 3D Procedure Manuals Using Hitachi's Assembly Navigation System
May 28, 2020 18:18 HKT/SGT
Hitachi Announces Change in the Effective Date for Company Split and Closing Date of Share Transfer
More news >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: